The impact of freezing of gait on functional dependency in Parkinson's disease with regard to motor phenotype.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 01 11 2019
accepted: 08 04 2020
pubmed: 26 4 2020
medline: 15 5 2021
entrez: 26 4 2020
Statut: ppublish

Résumé

Freezing of gait (FOG) is a disabling symptom more frequent in Parkinson's disease (PD) patients with postural instability gait difficulty (PIGD) phenotype. The aim of this study was to determine the prevalence of self-reported FOG in a large group of PD patients as well as assess its relationship with functional dependency with regard to motor phenotype. The data correspond to the baseline evaluation of the COPPADIS-2015 study. Patients with FOG were identified as those with a score of 1 or greater on item-3 of the freezing of gait questionnaire (FOG-Q). Functional dependency was defined as a Schwab and England (S&E) ADL scale score less than 80%. PIGD and non-PIGD (tremor dominant + indeterminate) groups were considered regarding to motor phenotype. Among the 689 PD patients (62.6 ± 8.9 years old, 59.8% males), 240 reported FOG (34.8%), whereas 63 presented functional dependency (9.1%). A total of 22.1% of patients with FOG presented functional dependency vs. only 2.2% of those without FOG (p < 0.0001). FOG was related to functional dependency (OR = 3.470; 95%CI 1.411-8.530; p = 0.007) after adjustment to age, gender, disease duration, daily equivalent levodopa dose, comorbidity (number of non-antiparkinsonian drugs/day), motor status (UPDRS-III), PIGD phenotype, motor complications (UPDRS-IV), NMS burden (NMSS total score), cognition (PD-CRS), and mood (BDI-II). However, according to motor phenotype, FOG was related to functional dependency only in PIGD patients (OR = 7.163; 95%CI 1.206-42.564; p = 0.030). Self-reported FOG is associated with functional dependency in PIGD but not in non-PIGD motor phenotype patients.

Sections du résumé

BACKGROUND AND OBJECTIVE OBJECTIVE
Freezing of gait (FOG) is a disabling symptom more frequent in Parkinson's disease (PD) patients with postural instability gait difficulty (PIGD) phenotype. The aim of this study was to determine the prevalence of self-reported FOG in a large group of PD patients as well as assess its relationship with functional dependency with regard to motor phenotype.
METHODS METHODS
The data correspond to the baseline evaluation of the COPPADIS-2015 study. Patients with FOG were identified as those with a score of 1 or greater on item-3 of the freezing of gait questionnaire (FOG-Q). Functional dependency was defined as a Schwab and England (S&E) ADL scale score less than 80%. PIGD and non-PIGD (tremor dominant + indeterminate) groups were considered regarding to motor phenotype.
RESULTS RESULTS
Among the 689 PD patients (62.6 ± 8.9 years old, 59.8% males), 240 reported FOG (34.8%), whereas 63 presented functional dependency (9.1%). A total of 22.1% of patients with FOG presented functional dependency vs. only 2.2% of those without FOG (p < 0.0001). FOG was related to functional dependency (OR = 3.470; 95%CI 1.411-8.530; p = 0.007) after adjustment to age, gender, disease duration, daily equivalent levodopa dose, comorbidity (number of non-antiparkinsonian drugs/day), motor status (UPDRS-III), PIGD phenotype, motor complications (UPDRS-IV), NMS burden (NMSS total score), cognition (PD-CRS), and mood (BDI-II). However, according to motor phenotype, FOG was related to functional dependency only in PIGD patients (OR = 7.163; 95%CI 1.206-42.564; p = 0.030).
CONCLUSIONS CONCLUSIONS
Self-reported FOG is associated with functional dependency in PIGD but not in non-PIGD motor phenotype patients.

Identifiants

pubmed: 32333181
doi: 10.1007/s10072-020-04404-7
pii: 10.1007/s10072-020-04404-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2883-2892

Investigateurs

A D Adarmes (AD)
M Almeria (M)
M G Alonso Losada (MG)
A Alonso Cánovas (A)
F Alonso Frech (F)
I Álvarez (I)
M Álvarez Sauco (M)
A Aneiros Díaz (A)
S Arnáiz (S)
S Arribas (S)
A Ascunce Vidondo (A)
M Aguilar (M)
M A Ávila (MA)
N Bernardo Lambrich (N)
H Bejr-Kasem (H)
M Blázquez Estrada (M)
M Botí (M)
C Borrue (C)
M T Buongiorno (MT)
C Cabello González (C)
I Cabo López (I)
N Caballol (N)
A Cámara Lorenzo (A)
F Carrillo (F)
F J Carrillo Padilla (FJ)
E Casas (E)
M J Catalán (MJ)
P Clavero (P)
A Cortina Fernández (A)
M Cosgaya (M)
A Cots Foraster (A)
A Crespo Cuevas (A)
E Cubo (E)
T de Deus Fonticoba (T)
O de Fábregues-Boixar (O)
M Díez-Fairen (M)
E Erro (E)
S Escalante (S)
E Estelrich Peyret (E)
N Fernández Guillán (N)
P Gámez (P)
M Gallego (M)
J García Caldentey (J)
C García Campos (C)
J M García Moreno (JM)
I Gastón (I)
D Guillén Fopiani (D)
M P Gómez Garre (MP)
J González Aloy (J)
I González-Aramburu (I)
J González Ardura (J)
B González García (B)
M J González Palmás (MJ)
G R González Toledo (GR)
A Golpe Díaz (A)
M Grau Solá (M)
G Guardia (G)
J Hernández Vara (J)
A Horta-Barba (A)
D Idoate Calderón (D)
J Infante (J)
S Jesús (S)
J Kulisevsky (J)
M Kurtis (M)
C Labandeira (C)
M A Labrador (MA)
F Lacruz (F)
M Lage Castro (M)
I Legarda (I)
N López Ariztegui (N)
L M López Díaz (LM)
L López Manzanares (L)
B López Seoane (B)
S Lucas Del Pozo (S)
Y Macías (Y)
M Mata (M)
G Martí Andres (G)
M J Martí (MJ)
J C Martínez Castrillo (JC)
P Martinez-Martin (P)
D McAfee (D)
M T Meitín (MT)
M Menéndez González (M)
C Méndez Del Barrio (C)
P Mir (P)
J Miranda Santiago (J)
M I Morales Casado (MI)
A Moreno Diéguez (A)
V Nogueira (V)
A Novo Amado (A)
S Novo Ponte (S)
C Ordás (C)
J Pagonabarraga (J)
I Pareés (I)
B Pascual-Sedano (B)
P Pastor (P)
A Pérez Fuertes (A)
R Pérez Noguera (R)
L Planellas (L)
M A Prats (MA)
C Prieto Jurczynska (C)
V Puente (V)
M Pueyo Morlans (M)
N Redondo Rafales (N)
L Rodríguez Méndez (L)
A B Rodríguez Pérez (AB)
F Roldán (F)
M Ruíz De Arcos (M)
J Ruíz Martínez (J)
P Sánchez Alonso (P)
M Sánchez-Carpintero (M)
G Sánchez Díez (G)
A Sánchez Rodríguez (A)
P Santacruz (P)
D Santos García (D)
J C Segundo Rodríguez (JC)
M Seijo (M)
M Sierra Peña (M)
B Solano Vila (B)
E Suárez Castro (E)
J P Tartari (JP)
C Valero (C)
L Vargas (L)
L Vela (L)
C Villanueva (C)
B Vives (B)
M D Villar (MD)

Auteurs

Diego Santos-García (D)

Section of Neurology, Complejo Hospitalario Universitario de A Coruña (CHUAC), HUAC, C / As Xubias 84, 15006, A Coruña, Spain. diegosangar@yahoo.es.

Teres de Deus-Fonticoba (T)

Hospital Arquitecto Marcide y Hospital Naval, Complejo Hospitalario Universitario de Ferrol (CHUF), Ferrol, A Coruña, Spain.

Ester Suárez Castro (E)

Hospital Arquitecto Marcide y Hospital Naval, Complejo Hospitalario Universitario de Ferrol (CHUF), Ferrol, A Coruña, Spain.

Ángel M Aneiros Díaz (Á)

Hospital Arquitecto Marcide y Hospital Naval, Complejo Hospitalario Universitario de Ferrol (CHUF), Ferrol, A Coruña, Spain.

María J Feal-Painceiras (MJ)

Section of Neurology, Complejo Hospitalario Universitario de A Coruña (CHUAC), HUAC, C / As Xubias 84, 15006, A Coruña, Spain.

Jose M Paz-González (JM)

Section of Neurology, Complejo Hospitalario Universitario de A Coruña (CHUAC), HUAC, C / As Xubias 84, 15006, A Coruña, Spain.

Carlos García-Sancho (C)

Section of Neurology, Complejo Hospitalario Universitario de A Coruña (CHUAC), HUAC, C / As Xubias 84, 15006, A Coruña, Spain.

Silvia Jesús (S)

Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.

Pablo Mir (P)

Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.

Lluís Planellas (L)

Hospital Clínic de Barcelona, Barcelona, Spain.

Juan García-Caldentey (J)

Centro Neurológico Oms 42, Palma de Mallorca, Spain.

Nuria Caballol (N)

Consorci Sanitari Integral, Hospital Moisés Broggi, Sant Joan Despí, Barcelona, Spain.

Inés Legarda (I)

Hospital Universitario Son Espases, Palma de Mallorca, Spain.

Jorge Hernández-Vara (J)

Hospital Universitario Vall d'Hebron, Barcelona, Spain.

Isabel González-Aramburu (I)

Hospital Universitario Marqués de Valdecilla, Santander, Spain.

María A Ávila-Rivera (MA)

Consorci Sanitari Integral, Hospital General de L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain.

María J Catalán (MJ)

Hospital Universitario Clínico San Carlos, Madrid, Spain.

Víctor Nogueira (V)

Hospital Da Costa de Burela, Lugo, Spain.

María Álvarez-Sauco (M)

Hospital General Universitario de Elche, Elche, Spain.

Lydia Vela (L)

Fundación Hospital de Alcorcón, Madrid, Spain.

Sonia Escalante (S)

Hospital de Tortosa Verge de la Cinta (HTVC), Tortosa, Tarragona, Spain.

Esther Cubo (E)

Complejo Asistencial Universitario de Burgos, Burgos, Spain.

Pilar Sánchez-Alonso (P)

Hospital Universitario Puerta de Hierro, Madrid, Spain.

María G Alonso-Losada (MG)

Hospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo (CHUVI), Vigo, Spain.

Nuria López-Ariztegui (N)

Complejo Hospitalario de Toledo, Toledo, Spain.

Pablo Martinez-Martin (P)

Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH